Concepedia

Josephine Kahn

JK

Statistics

Publications

4

Citations

451

H-Index

4

Active since

2017

Affiliations

Dana-Farber Cancer Institute(Current)

Brigham and Women's Hospital

Broad Institute

Harvard University

Massachusetts General Hospital

Josephine Kahn is an author at Dana-Farber Cancer Institute specializing in molecular oncology, oncology, and medicine.

Publications per year

2017–2023

4

Publications

4

PPM1D-truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cells

Josephine Kahn, Peter G. Miller, Alexander J. Silver et al. · Blood · 2018 · 219 citations · Full text

, , +10

SETD2 alterations impair DNA damage recognition and lead to resistance to chemotherapy in leukemia

Brenton G. Mar, S. Haihua Chu, Josephine Kahn et al. · Blood · 2017 · 149 citations · Full text

, , +14

PPM1D modulates hematopoietic cell fitness and response to DNA damage and is a therapeutic target in myeloid malignancy

Peter G. Miller, Adam S. Sperling, Christina Mayerhofer et al. · Blood · 2023 · 46 citations · Full text

, , +16

Allosteric inhibition of PPM1D serine/threonine phosphatase via an altered conformational state

Peter G. Miller, Murugappan Sathappa, Jamie A. Moroco et al. · Nature Communications · 2022 · 37 citations · Full text

, , +17

1–4 of 4